Podstawa prawna: art. 56. 1. 2 of Act on Public Offering.
Sofia, Bulgaria, January 13, 2023 – According to the requirements of art. 100t of LPOS, the Board of Directors of „Sopharma” AD (SFA: „BFB – Sofia”, SPH: Warsaw Stock Exchange) announces that on January 13, 2023, „Sopharma” AD received a corrected tender offer, registered with the Financial Supervision Commission from „DONEV INVESTMENTS HOLDING” AD – a shareholder directly owning 37,600,000 ordinary, non-available shares with voting rights, representing 27.89% of the capital and votes in the GMS of „SOPHARMA” AD, on the basis of art. 149b of the Law on the Public Offering of Securities for the purchase of shares from the remaining shareholders of „SOPHARMA” AD.
Więcej na: http://biznes.pap.pl/pl/reports/espi/all,0,0,0,1
kom espi zdz
Informacja dystrybuowana przez: pap-mediaroom.pl
